What drove CLV.AX stock higher pre-market on 25 Mar 2026?

Record H1 revenue and margin expansion from new product sales drove the move. Management cited strong product mix, an interim dividend of A$0.01, and revenue guidance for FY26 that underpinned the pre-market lift.

How does Clover’s valuation compare to peers for CLV.AX stock?

Clover's PE of 18.63 and PB of 1.72 are modest versus some consumer defensive peers. Low leverage and an EV/EBITDA near 10.03 support a neutral valuation picture relative to growth prospects.

What is Meyka AI’s price outlook for CLV.AX stock?

Meyka AI's forecast model projects **A$1.02** in 12 months, implying **15.07%** upside from A$0.885. Forecasts are model-based projections and not guarantees.

What risks should investors watch for CLV.AX stock?

Key risks include higher inventory levels that reduce operating cash flow, extended receivables (106.59 days), input cost inflation, and FX exposure. Execution risk on new products also matters for margins.

AU Stocks

Record revenue lifts CLV.AX stock pre-market 25 Mar 2026: margins point to FY26 upside

ByHuzaifa Zahoor March 24, 2026March 24, 2026

CLV.AX stock jumps after Clover Corporation Limited (ASX) reported record first-half revenue, lifting the pre-market price to A$0.885 on 25 Mar 2026. The Q1 update cited stronger product mix and new launches that expanded margins, while volume surged to 541,916 shares traded today. Investors will watch guidance for FY26 after a suite of slides and an earnings call highlighted an interim dividend of A$0.01 per share and a return on sales of 9.6%. Meyka AI’s platform flags improved cash conversion but higher inventory as the key near-term driver for the share path.